Director/PDMR Shareholding

RNS Number : 2257P
GlaxoSmithKline PLC
12 July 2010
 



 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £11.33 per Ordinary share on 9 July 2010 through the Company's Share Reward Plan ("the Plan") which the under-mentioned persons entered on 5 October 2001:

 

Mr A P Witty

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr J S Heslop

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr S M Bicknell

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr E J Gray

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr S A Hussain

Acquisition of 6 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr D Learmouth

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Dr D Pulman

Acquisition of 12 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr D S Redfern

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Ms C Thomas

Acquisition of 31 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr P J T Vallance

Acquisition of 11 Ordinary shares under the Dividend Reinvestment element of the Plan

 

 

The Company and the above-mentioned persons were advised of this information on 12 July 2010.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Deputy Company Secretary

12 July 2010


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQLLFFBDFFBBB

Companies

GSK (GSK)
UK 100

Latest directors dealings